Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.

Lund, Lars Christian; Rahbek, Martin Torp; Brown, Peter; Obel, Niels; Hallas, Jesper; Frederiksen, Henrik

Lund, Lars Christian; Rahbek, Martin Torp; Brown, Peter; Obel, Niels; Hallas, Jesper; Frederiksen, Henrik.

Affiliation

Lund LC; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Rahbek MT; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Brown P; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Hallas J; Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Frederiksen H; Department of Haematology, Odense University Hospital, Odense, Denmark.

Eur J Haematol ; 111(6): 946-950, 2023 Dec.

Article in En | MEDLINE | ID: mdl-37740535

Subject(s)

COVID-19; Hematologic Neoplasms; Humans; COVID-19/epidemiology; SARS-CoV-2; Cohort Studies; COVID-19 Vaccines; Hematologic Neoplasms/complications; Hematologic Neoplasms/diagnosis; Hematologic Neoplasms/epidemiology; Denmark/epidemiology

Key words

COVID-19; hematologic neoplasms; mortality

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2023 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google